Leo Pharma
Clinical trials sponsored by Leo Pharma, explained in plain language.
-
New hope for kids with severe eczema: drug trial launches
Disease control OngoingThis study tests a drug called tralokinumab in children aged 6 to 12 with moderate-to-severe eczema. The goal is to see how the drug works in the body and if it is safe. All children will also use moisturizer daily. The study lasts up to 194 weeks with many visits.
Phase: PHASE2 • Sponsor: LEO Pharma • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
New drug safety study in healthy volunteers withdrawn before starting
Knowledge-focused TerminatedThis study was designed to test the safety of a new drug called LEO 142397 in healthy volunteers. The trial was withdrawn before any participants were enrolled, so no results are available. The goal was to see how the body handles the drug and if it causes any side effects.
Phase: PHASE1 • Sponsor: LEO Pharma • Aim: Knowledge-focused
Last updated May 06, 2026 16:00 UTC